News2021-05-28T14:12:08+00:00
0723, 2020

Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology

Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology Publication in peer-reviewed journal Science demonstrates the foundation of the company’s evolution-based, data-driven engineering technology to build artificial functional enzymes Chicago, July 23, 2020 – A publication released in the peer-review journal Science today demonstrates the foundation of Evozyne’s evolution-based, data-driven engineering process for building [...]

063, 2020

Horizon Technology Finance and Emalex Biosciences Announce $15 Million Venture Loan Facility

Horizon Technology Finance and Emalex Biosciences Announce $15 Million Venture Loan Facility – Biopharmaceutical company advancing clinical research evaluating novel treatment for Tourette syndrome and childhood-onset fluency disorder – Farmington, Connecticut & Chicago, Illinois – June 3, 2020 – Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital [...]

0319, 2020

QuantX Artificial Intelligence Breast Cancer Diagnosis System Receives 2020 Gold Edison Award

QuantX Artificial Intelligence Breast Cancer Diagnosis System Receives 2020 Gold Edison Award The first FDA-cleared artificial intelligence diagnostic system for medical imaging, developed by Qlarity Imaging, a portfolio company of Paragon Biosciences, was selected as a “game-changing” innovation by a panel of global business leaders. Chicago, IL, March 19, 2020 – Qlarity Imaging today [...]

Archives
Go to Top